Cholesteryl esters

Biomarker2 papers

Humans1
Animals1

Latest

13

OphthalmologyHumans30 Sep

Genetically proxied CETP inhibition links to higher AMD risk

In drug-target Mendelian randomization, proxied CETP inhibition was associated with advanced AMD in Europeans (OR 1.45) and exudative AMD in East…In drug-target Mendelian randomization, proxied CETP inhibition was associated with advanced AMD in Europeans (OR 1.45) and exudative AMD in East Asians (OR 3.14).

bioRxivHumansPreprint22 Sep

Metabolomics highlights cardiovascular risk factor links to sphingolipid and one-carbon metabolism in asymptomatic adults

Amino acid metabolism

Yi ChuanReview17 Sep

Progress on cholesteryl ester transfer protein-related genes and CETP inhibitor therapy

NutrientsHuman trial27 Aug

Effects of Brussels Chicory and Concurrent Exercise Training on HDL Function and Subclass Profiles in Overweight College Students: A Pilot Randomized Controlled Trial

GSA 2025 AbstractHumans3 Jan

Integrating Unknown Metabolites to Optimize a Metabolomic Distress Score for Psychological Distress in Older Women

AAIC 2025 AbstractHumans25 Dec

Lipid blood biomarkers mediating olfaction with cognitive and mobility impairment

AAIC 2025 AbstractHuman trial23 Dec

Effects of Obicetrapib, a Potent Oral CETP Inhibitor, on Alzheimer's Disease Biomarkers in 1727 Patients with cardiovascular disease

AHA Scientific Sessions 2025 AbstractReview3 Nov

Efficacy and Safety of Obicetrapib in Dyslipidemia or Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis

AHA Scientific Sessions 2025 AbstractReview3 Nov

Obicetrapib in Patients with Dyslipidemia with or without Atherosclerotic Cardiovascular Disease Risk: A Meta-Analysis of Randomized Controlled Trials

AHA Scientific Sessions 2025 AbstractReview3 Nov

Evaluating Lipid-Lowering Efficacy Of Obicetrapib: An Updated Meta-Analysis of Clinical Trials